CASI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CASI Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-15 | $-0.55 | $-0.62 | 11.3 % |
Jun 2024 | 2024-08-16 | $-0.52 | $-0.63 | 17.5 % |
Mar 2024 | 2024-05-14 | $-0.71 | $-0.05 | -1320.0 % |
Dec 2023 | 2024-03-28 | $-0.45 | $-0.24 | -87.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-15 | $7.79M | $4.56M | 70.9 % |
Jun 2024 | 2024-08-16 | $3.98M | $4.43M | -10.2 % |
Mar 2024 | 2024-05-14 | $3.41M | $12.00M | -71.6 % |
Dec 2023 | 2024-03-28 | $6.87M | $9.41M | -27.0 % |
CASI Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3.
CASI Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3 and the Actual EPS was $-0.55, which beat the estimate of $-0.62.
CASI Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 15, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.